• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性肾脏疾病中肾功能的分期与测量]

[Staging and measurement of renal function in chronic renal conditions].

作者信息

Hartmann Anders, Holdaas Hallvard, Os Ingrid, Hunderi Odd Helge, Hallan Stein, Widerøe Tor Erik, Svarstad Einar, Selvig Kristian, Skjønsberg Helge, Toft Ingrid

机构信息

Nyreseksjonen, Medisinsk avdeling, Rikshospitalet.

出版信息

Tidsskr Nor Laegeforen. 2006 Apr 27;126(9):1198-200.

PMID:16670740
Abstract

Kidney failure has traditionally been categorised as mild, moderate or severe. Other poorly defined terms like uraemia and end-stage kidney disease have commonly been applied. During the last few years, an international consensus has emerged staging chronic kidney disease into 5 stages: stage 1 being glomerular filtration rate (GFR) > 90 ml/min and signs of kidney damage, stage 2 GFR 60-89 ml/min and signs of kidney damage, stage 3 being GFR 30-59 ml/min, stage 4 being GFR 15-29 ml/min, and stage 5 GFR < 15 ml/min. Kidney function should be calculated from creatinine-based formulas, or measured by isotope or iohexol clearances rather than as renal clearance of creatinine in timed urine samples. We address the importance and implications of these new definitions.

摘要

传统上,肾衰竭被分为轻度、中度或重度。诸如尿毒症和终末期肾病等其他定义不明确的术语也经常被使用。在过去几年中,国际上已达成共识,将慢性肾病分为5期:1期为肾小球滤过率(GFR)>90 ml/分钟且有肾脏损伤迹象;2期为GFR 60 - 89 ml/分钟且有肾脏损伤迹象;3期为GFR 30 - 59 ml/分钟;4期为GFR 15 - 29 ml/分钟;5期为GFR<15 ml/分钟。肾功能应根据基于肌酐的公式计算,或通过同位素或碘海醇清除率测量,而不是通过定时尿样中肌酐的肾清除率来测定。我们阐述了这些新定义的重要性及影响。

相似文献

1
[Staging and measurement of renal function in chronic renal conditions].[慢性肾脏疾病中肾功能的分期与测量]
Tidsskr Nor Laegeforen. 2006 Apr 27;126(9):1198-200.
2
Glomerular filtration rate measurement in cirrhotic patients with renal failure.肝硬化合并肾衰竭患者的肾小球滤过率测量
Clin Nephrol. 1998 Dec;50(6):342-6.
3
[Advances in detection, evaluation and management of chronic kidney disease].[慢性肾脏病的检测、评估与管理进展]
Laeknabladid. 2007 Mar;93(3):201-7.
4
Chronic kidney disease stage in renal transplantation classification using cystatin C and creatinine-based equations.使用胱抑素C和基于肌酐的方程对肾移植中的慢性肾脏病阶段进行分类。
Nephrol Dial Transplant. 2007 Oct;22(10):3013-20. doi: 10.1093/ndt/gfm318. Epub 2007 Jun 7.
5
Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.当肾小球滤过率(GFR)较低时,联合尿素和肌酐清除率与预测方程作为残余肾功能指标的比较。
QJM. 2008 Aug;101(8):619-24. doi: 10.1093/qjmed/hcn032. Epub 2008 Jun 6.
6
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.慢性心力衰竭和收缩功能障碍患者肾功能评估公式的缺点及预后价值
Circulation. 2006 Oct 10;114(15):1572-80. doi: 10.1161/CIRCULATIONAHA.105.610642. Epub 2006 Oct 2.
7
Measurement and estimation of GFR in children and adolescents.儿童和青少年肾小球滤过率的测量和估计。
Clin J Am Soc Nephrol. 2009 Nov;4(11):1832-43. doi: 10.2215/CJN.01640309. Epub 2009 Oct 9.
8
[Evaluation of glomerular filtration rate and proteinuria for the diagnosis of chronic kidney disease].[评估肾小球滤过率和蛋白尿用于慢性肾脏病的诊断]
Nephrol Ther. 2009 Jul;5(4):302-5. doi: 10.1016/j.nephro.2009.02.011. Epub 2009 May 5.
9
Assessing renal function from creatinine measurements in adults with chronic renal failure.通过肌酐测量评估慢性肾衰竭成人的肾功能。
Am J Kidney Dis. 1998 Jul;32(1):23-31. doi: 10.1053/ajkd.1998.v32.pm9669420.
10
Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.在南加州凯撒医疗机构实施美国肾脏病预后质量倡议(KDOQI)的慢性肾脏病(CKD)定义及分期指南。
Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S86-99. doi: 10.1053/j.ajkd.2008.07.052.

引用本文的文献

1
Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden.环硅酸锆钠治疗挪威和瑞典慢性肾脏病高钾血症患者的成本效果分析。
BMC Nephrol. 2022 Aug 12;23(1):281. doi: 10.1186/s12882-022-02903-7.